We also discovered and identified the downstream targets of PD-L1, and showed that PD-L1 functioned as a tumor-promoting factor mainly through regulating the PI3K/Akt, Erk, EMT, β-catenin, and targeting the WIP signaling pathways in lung cancer. Here, AKT1 is linked to lung carcinoma.